Allworth Financial LP Sells 593 Shares of The Clorox Company $CLX

Allworth Financial LP decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 8.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,626 shares of the company’s stock after selling 593 shares during the quarter. Allworth Financial LP’s holdings in Clorox were worth $796,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. American National Bank & Trust boosted its stake in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after purchasing an additional 89 shares in the last quarter. NewSquare Capital LLC boosted its position in shares of Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after purchasing an additional 193 shares during the last quarter. Hantz Financial Services Inc. acquired a new stake in shares of Clorox in the 2nd quarter valued at approximately $31,000. Ransom Advisory Ltd acquired a new stake in Clorox in the first quarter worth $35,000. Finally, GW&K Investment Management LLC lifted its holdings in Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after acquiring an additional 208 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.63% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company reduced their target price on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 28th. Bank of America reduced their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Finally, The Goldman Sachs Group lowered their price objective on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of $125.69.

Clorox Stock Performance

NYSE:CLX opened at $103.52 on Friday. The business’s fifty day moving average is $117.67 and its 200 day moving average is $123.73. The firm has a market cap of $12.63 billion, a price-to-earnings ratio of 15.88, a PEG ratio of 0.92 and a beta of 0.52. The Clorox Company has a 52-week low of $103.43 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue was down 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Research analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd were given a $1.24 dividend. The ex-dividend date of this dividend was Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.8%. Clorox’s dividend payout ratio is 77.86%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.